REALM IDx Announces National Health Coverage of GenMineTOP™ Cancer Genome Profiling System in Japan

ALISO VIEJO, Calif.–(BUSINESS WIRE)–REALM IDx, Inc., a health care company pioneering the field of integrated diagnostics, announced today that GenMineTOP Cancer Genome Profiling System (“the System”) has been awarded national health coverage in Japan and will begin full commercial launch of contract testing with strategic partner, LSI Medicine Corporation (Chiyoda-ku,…